1Zelefsky MJ,Hollister T,Raben A,et al.Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer[J].Int J Radiat Oncol Biol Phys,2000,47(5):1261-1266.
2Martinez-Monge R,Nag S,Nieroda CA,et al.Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver[J].Cancer,1999,85(6):1218-1225.
3Lee W,Daly BD,Dipetrillo TA,et al.Limited resection for non-small cell lung cancer:observed local control with implantation of I-125 brachytherapy seeds[J].Ann Thorac Surg,2003,75(1):237-243.
8Mohiuddin M, Rosato F, Barbot D, et al. Long- term resultsof combined modality treatment with I - 125 implantation for carcinoma of the pancreas [J]. IntJ Radiat Oncol Biol Phys,1992,23(2):305- 311.
9Anderson LL, Kuan HM, Ding IY.Clinical dosimetry with 1 - 125. In Gorge[M] .Modem interstitial and intracavitary radation cancer management. NewYork: Masson Publishing, 1981.
10Williamson JF. Physics of brachytherapy. Perez CA, Brady LW. Principles and practice of radiation oncology[M] .Third Edition, Philadelphia: Lip - pincott - Raven, 1997.
9Urdaneta AI, Yu JB, Wilson LD. Population based cancer registry analysis of primary tracheal carcinoma. Am J Clin Oncol,2011,34 :32- 37.
10Honings J, Gaissert HA, van der Heijden HF,et al. Clinical aspects and treatment of primary tracheal malignancies. Acta Otolaryngol, 2010,130 : 763-772.
